El Vínculo El Vínculo.
Closed European Union SuppliesFramework agreement

ACORD-CADRU ACHIZITIE MEDICAMENTE PENTRU PROGRAMUL NATIONAL DE ONCOLOGIE

Buyer: SC Onco Clinic S.A.

Published
13 March 2024
Submission deadline
15 April 2024, 15:00
Procedure
Open procedure
Documents
1
Notice number
00153322-2024
Reference
188231e3-a259-47f2-a135-198644563bbb
Official source
Official source

CPV codes

Description

Acord-cadru pentru achizitie medicamente PN-Oncologie necesare sectiei de Oncologie. Contractele subsecvente urmeaza sa se atribuie prin reluarea competitiei: Nu Acord-cadru cu maxim 3 agenti economici. Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificare/informatiilor suplimentare in a 10-a zi inainte de termenul limita stabilit pentru depunerea ofertelor Numarul de zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor: 20

Lots (70)

LotDescriptionCPV codeAmount
1 ACIDUM ZOLEDRONICUM
RO411
33652100 Agentes antineoplásicos
2 CARBOPLATINUM
RO411
33652100 Agentes antineoplásicos
3 CARBOPLATINUM
RO411
33652100 Agentes antineoplásicos
4 DOCETAXELUM
RO411
33652100 Agentes antineoplásicos
5 DOCETAXELUM 20MG/ML-4ML
RO411
33652100 Agentes antineoplásicos
6 DOCETAXELUM 20MG/ML-8ML
RO411
33652100 Agentes antineoplásicos
7 CALCII FOLINAS 10MG/ML-10ML
RO411
33652100 Agentes antineoplásicos
8 CYCLOPHOSPHAMIDUM
RO411
33652100 Agentes antineoplásicos
9 BLEOMYCINUM SULFAS 15MG/6ML
RO411
33652100 Agentes antineoplásicos
10 BLEOMYCINUM SULFAS 15MG/6ML
RO411
33652100 Agentes antineoplásicos
11 DOXORUBICINUM LIPOZOMALA
RO411
33652100 Agentes antineoplásicos
12 DOXORUBICINUM 2MG/ML-25ML
RO411
33652100 Agentes antineoplásicos
13 DOXORUBICINUM 2MG/ML-50ML
RO411
33652100 Agentes antineoplásicos
14 IFOSFAMIDUM
RO411
33652100 Agentes antineoplásicos
15 METHOTREXATUM
RO411
33652100 Agentes antineoplásicos
16 EPIRUBICINUM 2MG/ML-25ML
RO411
33652100 Agentes antineoplásicos
17 EPIRUBICINUM 2MG/ML-50ML
RO411
33652100 Agentes antineoplásicos
18 ETOPOSIDUM
RO411
33652100 Agentes antineoplásicos
19 GEMCITABINUM
RO411
33652100 Agentes antineoplásicos
20 W61569002 GEMCITABINUM
RO411
33652100 Agentes antineoplásicos
21 IRINOTECANUM
RO411
33652100 Agentes antineoplásicos
22 OXALIPLATINUM
RO411
33652100 Agentes antineoplásicos
23 OXALIPLATINUM 5MG/ML-20ML
RO411
33652100 Agentes antineoplásicos
24 PACLITAXELUM 6MG/ML-16.67ML
RO411
33652100 Agentes antineoplásicos
25 PACLITAXELUM
RO411
33652100 Agentes antineoplásicos
26 PACLITAXELUM 6MG/ML-50ML
RO411
33652100 Agentes antineoplásicos
27 MESNUM
RO411
33652100 Agentes antineoplásicos
28 BEVACIZUMABUM
RO411
33652100 Agentes antineoplásicos
29 BEVACIZUMABUM 25MG/ML-16ML
RO411
33652100 Agentes antineoplásicos
30 TRANSTUZUMABUM EMTASINUM
RO411
33652100 Agentes antineoplásicos

Award criteria

Official publications

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 15 April 2024, 15:00. Check the official source, as dates can be modified.
Who is the buyer of this tender?
The contracting authority is SC Onco Clinic S.A. (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.